Legacy Financial Advisors, Inc.

Position in INCY — Incyte Corp

CIK 1730810 COVINGTON, KY

Position in INCY

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$350,622

+$45,203 QoQ

Shares Held

3,093

-4.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#587

of 854 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Legacy Financial Advisors, Inc. holds $3,774,599 across 5 Biotechnology names. INCY ranks #4 (9.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,139	$1,559,235
2	REGN	Regeneron Pharmaceuticals, Inc.	1,438	$896,650
3	IBRX	ImmunityBio, Inc.	81,230	$711,168
4	INCY	Incyte Corp This page	3,093	$350,622
5	EXEL	Exelixis, Inc.	4,722	$256,924

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$350,622	3,093	-4.7%	Shares	Sole	2026-08-05
2026-03-31	$305,419	3,245	+28.1%	Shares	Sole	2026-04-30
2025-12-31	$250,283	2,534	—	Shares	Sole	2026-02-04
No filing history on record for this holder in this stock.